The Latest Cardiac and Vascular News
Continued focus on providing nationwide access to patients and physicians to innovative wearable ECG technologies despite updated Novitas and First Coast Reimbursement Rates and Competitive Market Exit SEATTLE–(BUSINESS WIRE)–Cardiac Insight, Inc., a healthcare innovator specializing in wearable cardiac sensors and proven automated electrocardiogram (ECG) analysis, remains committed to delivering highly […]
MultiPulse Therapy™ (MPT™) achieved 71% termination of acute, induced atrial fibrillation (AF) episodes at energy levels deemed to be tolerable for patients1,2 MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has published a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology titled Novel Low-Voltage MultiPulse Therapy to Terminate Atrial Fibrillation. The study […]
SAN FRANCISCO–(BUSINESS WIRE)–Bodyport, the digital health company focused on the detection and management of heart disease, today announced that it has named Amit Rushi as Chief Commercial Officer (CCO) and Phyllis Whiteley as Chair of the Board of Directors. With this newly created role, Amit Rushi will serve as part […]
− NorthStar has provided reliable molybdenum-99 (Mo-99)/technetium-99m (Tc-99m) supply for more than two years as the only U.S. commercial Mo-99 producer − Second NorthStar Mo-99 production and processing facility nearing completion ensuring even more reliable supply and additional Mo-99 production capability − RadioGenix® System sales continue growth, reliably providing hundreds of thousands of Tc-99m […]
Thrombectomy Device with Off-Circuit Mechanical Aspiration Design for Treatment of Undesirable Intravascular Material in Venous System and Peripheral Vasculature LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology today announced that on April 9, 2021, it […]
ENGLEWOOD, Colo., April 12, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q1 2021. Thomas Sandgaard, CEO of Zynex said: “Our order growth in Q1 was strong at […]
Innovative treatment for patients with respiratory and cardiovascular disease expands ZOLL’s critical-care portfolio CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, today announced that it has acquired Respicardia, Inc., a provider of novel implantable neurostimulators for the treatment of moderate to severe […]
An acceleration of development in order to advance the marketing horizon up to 3 years, to conquer an addressable market of over one billion euros Valbiotis presents preclinical data on the plant-derived active substance TOTUM•854, designed to reduce blood pressure, at the Annual Joint Meeting of the European Society of […]
– Single Doses of Investigational ALN-AGT Achieved Sustained Reductions in Serum Angiotensinogen (AGT) at 12 Weeks Resulting in Reduced Blood Pressure – – Durability of AGT Knockdown Supports the Potential of Once Quarterly or Biannual Dosing – – ALN-AGT was Generally Well Tolerated, with No Serious Treatment-Related Adverse Events or […]
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Moray Medical announced today that it has closed a total of $5.7 million in seed funding, an increase of $2.4 million compared to the initial raise reported on 01/27/2021. Investors included 415 CAPITAL (lead), Heal Capital, as well as a number of prominent medtech entrepreneurs, such as Fred St. Goar, MD, inventor […]
